Ewald van den Bremer, PhDSenior Scientist at Genmab BVSpeaker
Profile
Ewald van den Bremer worked in antibody biology and biotechnology for more than 12 years. He holds a Ph.D. in biomolecular mass spectrometry from Utrecht University (2004) and worked at Genmab since 2006. Ewald is as an expert in analytical chemistry of biomolecules and antibodies in particular. Contributed to the research and development of the therapeutic antibodies ofatumumab (Arzerra®) and daratumumab (Darzalex®) and is an inventor of the DuoBody® technology that enables the development of bispecific antibodies. His group is mainly focused on advanced mass spectrometry-based methods for the analysis of innovative antibody therapeutics.